STOCK TITAN

LifeVantage Declares Quarterly Dividend

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
dividends

LifeVantage Corporation (LFVN), a health and wellness company, has announced a quarterly cash dividend of $0.045 per share of common stock. The dividend represents a 12.5% increase from the previous quarter. The dividend will be paid on June 13, 2025, to stockholders of record at the close of business on May 30, 2025. LifeVantage specializes in products designed to activate optimal health processes at the cellular level.

Loading...
Loading translation...

Positive

  • 12.5% increase in quarterly dividend payment
  • Demonstrates company's commitment to returning value to shareholders
  • Indicates financial stability and positive cash flow

Negative

  • None.

News Market Reaction – LFVN

-6.60%
1 alert
-6.60% News Effect

On the day this news was published, LFVN declined 6.60%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

SALT LAKE CITY, May 06, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company’s Board of Directors has approved a quarterly cash dividend of $0.045 per share of common stock, which will be paid June 13, 2025 to all stockholders of record at the close of business on May 30, 2025. This represents an increase in the dividend amount by 12.5% over the previous quarter.

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs for health. The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, the newest MindBody GLP-1 System™, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System®, as well as AXIO® nootropic energy drink mixes, the full TrueScience® line of skin and hair care products, and Petandim®, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.

Cautionary Note Regarding Forward Looking Statements

This document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such as "believe," "will," "hopes," "intends," "estimates," "expects," "projects," "plans," "anticipates," "look forward to," "goal," “may be,” and variations thereof, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. The declaration and/or payment of a dividend during any quarter provides no assurance as to future dividends, and the timing and amount of future dividends, if any, could vary significantly in comparison both to past dividends and to current expectations. Examples of forward-looking statements include, but are not limited to, statements we make regarding expected financial performance, including revenue and margins, executing against and the benefits of our key initiatives, future growth, including geographic and product expansion, expected financial performance, and expected dividend payments in future quarters. Such forward-looking statements are not guarantees of performance and the Company's actual results could differ materially from those contained in such statements. These forward-looking statements are based on the Company's current expectations and beliefs concerning future events affecting the Company and involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. These risks and uncertainties include, among others, further deterioration to the global economic and operating environments, as well as those discussed in greater detail in the Company's Annual Report on Form 10-K and the Company's Quarterly Report on Form 10-Q under the caption "Risk Factors," and in other documents filed by the Company from time to time with the Securities and Exchange Commission (the “SEC”). The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document. All forward-looking statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this document, except as required by law.

Investor Relations Contact:

Reed Anderson, ICR
(646) 277-1260
reed.anderson@icrinc.com


FAQ

What is LifeVantage's (LFVN) new quarterly dividend amount for 2025?

LifeVantage's new quarterly dividend is $0.045 per share of common stock, representing a 12.5% increase from the previous quarter.

When will LifeVantage (LFVN) pay its quarterly dividend in June 2025?

LifeVantage will pay its quarterly dividend on June 13, 2025, to stockholders of record as of May 30, 2025.

By what percentage did LifeVantage increase its dividend in May 2025?

LifeVantage increased its quarterly dividend by 12.5% compared to the previous quarter.

What is the record date for LifeVantage's Q2 2025 dividend?

The record date for LifeVantage's dividend is May 30, 2025, at the close of business.
Lifevantage Corp

NASDAQ:LFVN

View LFVN Stock Overview

LFVN Rankings

LFVN Latest News

LFVN Latest SEC Filings

LFVN Stock Data

62.43M
10.58M
Packaged Foods
Pharmaceutical Preparations
Link
United States
LEHI